Health Minister Mark Butler has again stepped in to override the direction emerging from a federal advisory committee, abandoning a planned reclassification of intravitreal eye injections after warnings the change could harm patients financially and disrupt access to essential treatment.
-
Latest News
Labor’s FoI backdown is a welcome victory for transparency and accountability
Had the now-scrapped changes to FoI laws been in place in recent years, it is likely that the previously unlawful arrangements for the Opiate Dependence Treatment Program and the employment workaround that led a health department official to secretly release confidential company pricing information, leading to its publication in the infamous 'Vancouver' poster, would never have been exposed.
-
Latest News Mark Butler steps in to block eye injection funding change after patient warnings March 10, 2026
-
Latest News Pharmac says new agreement has improved access to treatment for New Zealanders March 10, 2026New Zealand's Pharmac says a new multiproduct agreement with Roche is delivering benefits for patients and the health system, reducing treatment times and freeing up thousands of infusion hours across hospitals.
-
Latest News BPDInsights.ai has arrived as a new way to access knowledge March 9, 2026Over the past four months, the publication’s archive of more than 16,000 articles, totalling over seven million words, has been transformed into a generative 'beta' large language model. We describe it as a natural language insights platform.
-
Latest News How to Use BPDInsights.ai - to learn and to train the platform March 9, 2026BPDInsights.ai performs best when users ask clear, direct questions, with some specifics and multiple layers. It simply uses these inputs to determine the user's intent.
-
Latest News Life sciences leaders gather in Sydney to advance women’s leadership on International Women’s Day March 5, 2026More than 650 leaders from across Australia’s life sciences community will gather in Sydney to mark International Women’s Day at the Women in Life Sciences Leadership Summit and Luncheon, hosted by AusBiotech and Medicines Australia.
-
Latest News The myth of affordability - Australia’s medicines debate is really about the choices we make March 5, 2026In the current budget year, the Australian government is expected to spend roughly $780 billion. Around $125 billion will go to healthcare. Within this enormous envelope, however, the amount allocated to innovative medicines is vanishingly small. This reflects a choice that is consistently misrepresented as an affordability challenge. Affordability is the consequence of the choice, not a reason.
-
Latest News Wesfarmers Health expands medicine access with major new Cairns fulfilment centre March 5, 2026Wesfarmers Health has opened a major new fulfilment centre in Cairns, marking a significant investment aimed at improving the supply of medicines and health products to communities across Far North and regional Queensland.
-
Latest News CSL Seqirus to supply Canada with pandemic influenza vaccines from new Melbourne facility March 5, 2026Australia will play a key role in protecting Canadians in the event of a future influenza pandemic under a new agreement between CSL Seqirus and the Canadian government.
-
Latest News Pfizer and AbbVie recognised among Australia’s Best Workplaces for Women March 5, 2026The list, released by Great Place To Work, identifies employers that combine strong business performance with workplace cultures designed to support women at every stage of their careers.
-
Latest News Pharma teams power Kosi Challenge toward $500,000 fundraising milestone March 5, 2026With just one week remaining in this year’s Rare Cancers Australia Kosi Challenge Pharma Cup, the pharmaceutical industry is helping drive a fundraising surge that is set to push the overall total beyond half a million dollars.
-
Latest News Setting the standard for safe and accountable virtual healthcare in Australia March 4, 2026Australia’s rapid expansion of telehealth has transformed how patients access care, but it has also raised an important question about how virtual healthcare providers ensure safety, quality and accountability in a digital environment.
-
Latest News A system built for a past is struggling to meet the challenge of today, let alone the future March 4, 2026While it is understandable that companies will prioritise large and potentially lucrative markets, surely the correct response from smaller or mid-size markets is to make their settings more attractive? Unless the response is driven by ideology.
-
Australian Biotech PYC Therapeutics secures strong backing as retail offer adds $47 million to capital raise March 4, 2026PYC Therapeutics (ASX:PYC) has completed the retail component of a major capital raising, adding approximately $47 million to its funding as the biotechnology company continues to advance its precision medicine programs for genetic diseases.
-
Australian Biotech Australian medtech innovators move closer to procurement through national capability program March 4, 2026Seven Australian medtech companies are being supported to accelerate their pathway into local procurement through a national capability program aimed at strengthening the adoption of homegrown medical technologies.
-
Latest News New report says faster and fairer access to medicines within reach for New Zealand March 3, 2026Owen Smith, General Manager of Bristol Myers Squibb New Zealand, said, "There was a clear and strong consensus from those consulted that reform is necessary to improve access to medicines in New Zealand to support better outcomes for patients and, over time, help reduce pressure across the wider health system.”
-
Latest News Pharma teams surge past $225,000 in 2026 Rare Cancers Australia Kosi Challenge March 3, 2026With ten days remaining in this year’s Rare Cancers Australia Kosi Challenge Pharma Cup, the pharmaceutical industry has already demonstrated remarkable momentum, contributing more than $225,000 to the overall fundraising total of $420,000 to date.
-
Latest News FDA approved new cancer therapy and delivers patient access in just 44 days March 3, 2026In the United States, where the health system maintains a strong structural bias toward rapid access once the regulator approves a therapy, the 44-day outcome translates into virtually immediate insured access for more than 90 per cent of Americans through a mix of private and public coverage.
-
Latest News Genetic breakthrough brings new hope for Australians living with multiple sclerosis March 3, 2026Australian researchers are set to transform how scientists understand multiple sclerosis by developing a platform that can analyse more than 100 genetic risk factors simultaneously, marking a pivotal step toward more precise treatments and better long-term outcomes.
-
Latest News Australia counts the massive cost of obesity as new report warns of a growing economic crisis March 2, 2026Australia is paying a steep and largely invisible price for obesity, with a new report funded by Lilly estimating the condition is draining $45 billion from the national economy each year, or about $123 million every day.
Australian Biotech
-
New cancer research highlights potential of narmafotinib to koost KRAS Inhibitor therapies
March 9, 2026 -
Lateral Pharma secures key U.S. patent for novel neuropathic pain therapy
March 9, 2026 -
Nanosonics achieves key FDA clearance as CORIS Endoscope coverage expands
March 9, 2026 -
Firebrick Pharma targets breakout year in 2026 as Nasodine expansion accelerates
March 4, 2026 -
AdAlta strengthens clinical push for breakthrough solid cancer therapy
March 4, 2026
Other Health
-
When work can get in the way of care for endometriosis
March 1, 2026 -
AI-driven health performance platform launches in Australia
December 3, 2025 -
Burnt-Out Australians rush to health appointments as year-end pressure peaks
December 2, 2025 -
Five Australians honoured for leadership and community advocacy in evolving HIV response
December 1, 2025 -
Australia releases first national estimate of women living with metastatic breast cancer
November 27, 2025
Latest Video
New Stories
-
Labor’s FoI backdown is a welcome victory for transparency and accountability
March 10, 2026 - - Latest News -
Mark Butler steps in to block eye injection funding change after patient warnings
March 10, 2026 - - Latest News -
Pharmac says new agreement has improved access to treatment for New Zealanders
March 10, 2026 - - Latest News -
Island Pharmaceuticals expands antiviral program through Burnet Institute collaboration
March 9, 2026 - -
New cancer research highlights potential of narmafotinib to koost KRAS Inhibitor therapies
March 9, 2026 - - Australian Biotech -
Lateral Pharma secures key U.S. patent for novel neuropathic pain therapy
March 9, 2026 - - Australian Biotech -
Nanosonics achieves key FDA clearance as CORIS Endoscope coverage expands
March 9, 2026 - - Australian Biotech


